Lineage Cell Therapeutics (LCTX) Exchange Rate Effect (2010 - 2026)
Lineage Cell Therapeutics' (LCTX) quarterly Exchange Rate Effect came in at -$5000.0 in Q1 2026, up 93.15% year-on-year from -$2588.7 in Q1 2025, and down 102.78% quarter-over-quarter from $180000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Lineage Cell Therapeutics' Exchange Rate Effect history runs 17 years deep, the most recent figure standing at -$5000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 93.15% year-over-year to -$5000.0 in Q1 2026; TTM through Mar 2026 was $464000.0, a 573.47% increase from a year earlier, with the FY2025 full-year figure at $396000.0, up 516.84% from the prior year.
- Exchange Rate Effect fell to -$5000.0 in Q1 2026 per LCTX's latest filing, from $180000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $293000.0 in Q2 2025 and bottomed at -$634000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$70000.0 (2024), against an average of -$48647.1.
- Across the five-year window, Exchange Rate Effect slumped 7144.44% in 2022 and surged 620.0% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$78000.0 in 2022, then soared by 461.54% to $282000.0 in 2023, then plunged by 91.13% to $25000.0 in 2024, then jumped by 620.0% to $180000.0 in 2025, then tumbled by 102.78% to -$5000.0 in 2026.
- Per Business Quant, the three latest LCTX Exchange Rate Effect figures stand at -$5000.0 (Q1 2026), $180000.0 (Q4 2025), and -$4000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Mar 31, 2025 | -73,000.00 |
| Mar 31, 2025 | -73,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | -88,000.00 |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | 282,000.00 |
| Dec 31, 2023 | 282,000.00 |